* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
VEGF-stimulated human umbilical vein endothelial cells (HUVECs)
N/A nM (reported value)
In vivo mice.
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
See also PVV peptide , which also results in tumor growth suppression. See also DRW peptide , which contains the same WRP epitope resulting in suppression of tumor growth.